CAXTON CORP - Q1 2021 holdings

Add to watchlist

$154 Million is the total value of CAXTON CORP's 69 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 79.5% .

All
New
Buy
Sell
Exit
Unchanged
 Value Shares↓ Weighting
MTEM  MOLECULAR TEMPLATES INC$26,792,000
+34.4%
2,122,9910.0%17.40%
+40.1%
SBBP SellSTRONGBRIDGE BIOPHARMA PLC$22,310,000
+13.5%
8,083,442
-0.1%
14.49%
+18.3%
CRDF  CARDIFF ONCOLOGY INC$19,583,000
-48.5%
2,114,8400.0%12.72%
-46.4%
SVRA NewSAVARA INC$11,965,000–5,752,215
+100.0%
7.77%–
SCYX SellSCYNEXIS INC$11,179,000
-0.9%
1,407,886
-4.5%
7.26%
+3.3%
KALA BuyKALA PHARNACEUTICALS INC$9,638,000
+24.4%
1,430,021
+25.2%
6.26%
+29.7%
SRRA SellSIERRA ONCOLOGY INC$7,649,000
-25.9%
443,959
-31.1%
4.97%
-22.8%
CTIC SellCTI BIOPHARMA CORP$7,318,000
-39.4%
2,514,647
-32.9%
4.75%
-36.8%
GLD SellSPDR GOLD TR$6,530,000
-11.0%
40,820
-0.8%
4.24%
-7.3%
RZLT  REZOLUTE INC$2,995,000
-41.1%
424,2430.0%1.94%
-38.7%
ADXN  ADDEX THERAPEUTICS LTDsponsored ads$2,792,000
-21.7%
265,9400.0%1.81%
-18.4%
LUXA NewLUX HEALTH TECH ACQUISITION$2,054,000–200,000
+100.0%
1.33%–
AACU NewARES ACQUISITION CORPORATIONunit 99/99/9999$1,420,000–142,000
+100.0%
0.92%–
AJAX SellAJAX I$1,109,000
-64.3%
108,074
-56.8%
0.72%
-62.8%
MRAC NewMARQUEE RAINE ACQUISITION CO$1,042,000–105,500
+100.0%
0.68%–
ISEE BuyIVERIC BIO INC$911,000
-2.4%
147,366
+9.2%
0.59%
+1.7%
HMCOU  HUMANCO ACQUISITION CORPunit 12/08/2023$902,000
-4.2%
85,5000.0%0.59%
-0.2%
EIGR BuyEIGER BIOPHARMACEUTICALS INC$833,000
-14.3%
94,083
+19.0%
0.54%
-10.7%
BTWN SellBRIDGETOWN HOLDINGS LTD$680,000
-39.6%
62,688
-13.8%
0.44%
-36.9%
FLAC NewFRAZIER LIFESCIENCES ACQU CO$637,000–64,000
+100.0%
0.41%–
PTMN SellPORTMAN RIDGE FIN CORP$633,000
+10.9%
293,144
-2.0%
0.41%
+15.4%
SSAAU NewSCIENCE STRATEGIC ACQ ALPHAunit 01/20/2026$616,000–62,000
+100.0%
0.40%–
SCOAU  SCION TECH GROWTH Iunit 12/17/2025$588,000
-2.6%
58,5000.0%0.38%
+1.6%
ONCS NewONCOSEC MED INC$553,000–115,866
+100.0%
0.36%–
DIS BuyDISNEY WALT CO$469,000
+38.3%
2,544
+36.0%
0.30%
+44.5%
MA BuyMASTERCARD INCORPORATEDcl a$449,000
+59.8%
1,260
+60.1%
0.29%
+66.9%
GOOG BuyALPHABET INCcap stk cl c$444,000
+80.5%
214
+52.9%
0.29%
+88.2%
WHR BuyWHIRLPOOL CORP$443,000
+95.2%
2,008
+59.5%
0.29%
+104.3%
GIGGU NewGIGCAPITAL4 INCunit 99/99/9999$444,000–45,000
+100.0%
0.29%–
CVNA BuyCARVANA COcl a$436,000
+51.9%
1,660
+38.6%
0.28%
+58.1%
FB BuyFACEBOOK INCcl a$434,000
+84.7%
1,475
+71.5%
0.28%
+93.2%
PYPL BuyPAYPAL HLDGS INC$427,000
+43.8%
1,757
+38.7%
0.28%
+49.7%
V BuyVISA INC$427,000
+57.0%
2,018
+62.2%
0.28%
+62.9%
SPGI BuyS&P GLOBAL INC$419,000
+82.2%
1,189
+69.9%
0.27%
+90.2%
TDG BuyTRANSDIGM GROUP INC$417,000
+43.8%
710
+51.4%
0.27%
+49.7%
CDLX BuyCARDLYTICS INC$416,000
+1.5%
3,793
+32.2%
0.27%
+5.5%
FICO BuyFAIR ISAAC CORP$414,000
+46.8%
851
+54.2%
0.27%
+52.8%
INTU BuyINTUIT$414,000
+53.3%
1,080
+52.1%
0.27%
+60.1%
MSFT BuyMICROSOFT CORP$413,000
+62.6%
1,751
+53.3%
0.27%
+69.6%
MCO BuyMOODYS CORP$407,000
+62.8%
1,362
+57.8%
0.26%
+69.2%
MDLZ BuyMONDELEZ INTL INCcl a$403,000
+58.0%
6,879
+57.8%
0.26%
+64.8%
SWBKU NewSWITCHBACK II CORPORATIONunit 99/99/9999$397,000–39,000
+100.0%
0.26%–
AMT BuyAMERICAN TOWER CORP NEW$394,000
+70.6%
1,648
+60.5%
0.26%
+77.8%
NFLX BuyNETFLIX INC$392,000
+47.9%
752
+53.2%
0.26%
+54.5%
CHTR BuyCHARTER COMMUNICATIONS INC Ncl a$373,000
+48.6%
604
+59.4%
0.24%
+55.1%
SRNGU NewSOARING EAGLE ACQUISITION COunit 02/23/2026$364,000–36,000
+100.0%
0.24%–
CRM BuySALESFORCE COM INC$358,000
+51.1%
1,690
+58.8%
0.23%
+57.4%
ALDX NewALDEYRA THERAPEUTICS INC$351,000–29,552
+100.0%
0.23%–
BOASU NewBOA ACQUISITION CORPunit 99/99/9999$338,000–34,070
+100.0%
0.22%–
GMIIU NewGORES METROPOULOS II INCunit 01/31/2028$323,000–32,000
+100.0%
0.21%–
SVFA NewSVF INVESTMENT CORP$285,000–27,900
+100.0%
0.18%–
FTOC NewFTAC OLYMPUS ACQUISITION COR$264,000–25,000
+100.0%
0.17%–
HEC NewHUDSON EXECUTIVE INVT CORP$248,000–25,000
+100.0%
0.16%–
ISOSU NewISOS ACQUISITION CORPORATIONunit 99/99/9999$239,000–24,000
+100.0%
0.16%–
PV NewPRIMAVERA CAPITAL ACQUIST CO$235,000–24,000
+100.0%
0.15%–
PICCU NewPIVOTAL INVESTMENT CORP IIIunit 01/28/2028$168,000–16,800
+100.0%
0.11%–
HLXA  HELIX ACQUISITION CORP$163,000
-10.4%
16,0090.0%0.11%
-6.2%
SPRQ NewSPARTAN ACQUISITION CORP II$115,000–11,000
+100.0%
0.08%–
BTWNW  BRIDGETOWN HOLDINGS LTD*w exp 09/30/202$116,000
-33.7%
39,7730.0%0.08%
-31.2%
VGAC NewVG ACQUISITION CORP$112,000–11,000
+100.0%
0.07%–
DGNR NewDRAGONEER GROWTH OPPORTUN CO$112,000–11,000
+100.0%
0.07%–
RTP NewREINVENT TECHNOLOGY PARTNERScl a$112,000–11,000
+100.0%
0.07%–
NGAC NewNEXTGEN ACQUISITION CORPcl a$109,000–11,000
+100.0%
0.07%–
RMGCU NewRMG ACQUISITION CORP IIIunit 02/08/2026$109,000–11,000
+100.0%
0.07%–
AJAXWS NewAJAX I*w exp 10/27/202$106,000–62,500
+100.0%
0.07%–
LUXAW NewLUX HEALTH TECH ACQUISITION*w exp 11/30/202$99,000–66,666
+100.0%
0.06%–
MRACW NewMARQUEE RAINE ACQUISITION CO*w exp 12/01/202$33,000–26,375
+100.0%
0.02%–
FLACW NewFRAZIER LIFESCIENCES ACQU CO*w exp 11/30/202$19,000–21,333
+100.0%
0.01%–
PVWS NewPRIMAVERA CAPITAL ACQUIST CO*w exp 01/19/202$10,000–12,000
+100.0%
0.01%–
MEIP ExitMEI PHARMA INC$0–-50,000
-100.0%
-0.08%–
FLACU ExitFRAZIER LIFESCIENCES ACQU COunit 12/09/2025$0–-64,000
-100.0%
-0.41%–
MRACU ExitMARQUEE RAINE ACQUISITION COunit 12/01/2025$0–-105,500
-100.0%
-0.71%–
LUXAU ExitLUX HEALTH TECH ACQUISITIONunit 11/30/2027$0–-200,000
-100.0%
-1.43%–
XL ExitXL FLEET CORP$0–-300,000
-100.0%
-4.44%–
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-05-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MOLECULAR TEMPLATES INC24Q2 202330.7%
STRONGBRIDGE BIOPHARMA PLC22Q3 202173.1%
GARRISON CAP INC18Q3 20209.9%
BERKSHIRE HATHAWAY INC DEL17Q3 20195.8%
EIGER BIOPHARMACEUTICALS INC17Q3 20221.7%
AGILE THERAPEUTICS INC16Q1 201855.5%
KALA PHARNACEUTICALS INC16Q4 202117.6%
CM FIN INC16Q1 20197.8%
SYNTA PHARMACEUTICALS CORP15Q2 201699.9%
CTI BIOPHARMA CORP14Q4 20218.7%

View CAXTON CORP's complete holdings history.

Latest significant ownerships (13-D/G)
CAXTON CORP Q1 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Addex Therapeutics Ltd.February 14, 2023718,8490.9%
Cardiff Oncology, Inc.February 14, 2023983,6072.2%
Rezolute, Inc.February 14, 20231,860,5185.0%
Xeris Biopharma Holdings, Inc.February 14, 20235,973,3244.4%
CTI BIOPHARMA CORPFebruary 14, 20222,239,3002.3%
Sierra Oncology, Inc.February 14, 20221,119,3227.0%
Strongbridge Biopharma plcSold outJanuary 05, 202200.0%
SUNESIS PHARMACEUTICALS INCSold outFebruary 16, 202100.0%
Alcentra Capital CorpFebruary 14, 20201,005,0007.8%
Garrison Capital Inc.February 14, 20201,223,0967.6%

View CAXTON CORP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14
SC 13G/A2023-02-14

View CAXTON CORP's complete filings history.

All filings

View complete filings history.

Compare quarters

Export CAXTON CORP's holdings

CSVXLS